A critical discovery in cancer study is occurring with the use of nanobodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in several kinds of malignancies, leading https://sparxsocial.com/story792923/vhh-fragments-revive-p53-the-new-pathway-for-tumor-management